The production of pharmaceutical intermediates demands rigorous quality control and adherence to strict manufacturing standards. For compounds like the Isopropylidene Ticagrelor Intermediate (CAS 274693-26-4), which are integral to the synthesis of potent cardiovascular drugs, these standards are non-negotiable. NINGBO INNO PHARMCHEM CO.,LTD. understands that the integrity of the final Active Pharmaceutical Ingredient (API) hinges on the quality of its precursors. Therefore, manufacturers prioritize high purity and compliance with global regulatory requirements.

The Isopropylidene Ticagrelor Intermediate is typically a white powder, and its critical attribute is its high purity, often exceeding 99%. This level of purity is achieved through meticulous synthesis processes and stringent quality checks at every stage of production. Certifications such as Good Manufacturing Practice (GMP) and ISO 9001 are often sought and maintained by reputable suppliers. GMP compliance ensures that the intermediate is consistently produced and controlled according to quality standards appropriate to its intended use, while ISO 9001 certification signifies a robust quality management system.

These certifications provide end-users with confidence in the reliability and safety of the Isopropylidene Ticagrelor Intermediate for their drug manufacturing operations. The detailed specifications, including molecular formula (C26H32F2N6O4S) and molecular weight (562.63), are critical for process chemists and formulators. When seeking to buy Isopropylidene Ticagrelor Intermediate, buyers should always look for suppliers who can provide comprehensive documentation, including Certificates of Analysis (CoA), to verify purity and specifications.

NINGBO INNO PHARMCHEM CO.,LTD. is committed to upholding these high manufacturing standards. We recognize that our role as a supplier of pharmaceutical chemicals is to facilitate the development of effective treatments. By focusing on the quality and reliability of essential intermediates like CAS 274693-26-4, we contribute to the broader goal of improving patient outcomes in cardiovascular medicine. Our supply chain is built on principles of quality assurance, ensuring that our partners receive products that meet their exacting requirements.